ErythroPOietin alfa to prevent mortality and reduce severe disability in critically ill TRAUMA patients: a multicentre, stratified, double blind, placebo randomised controlled trial. (The EPO-TRAUMA trial)

Project: Research

Short titleEPO-TRAUMA
AcronymEPO-TRAUMA
StatusActive
Effective start/end date1/04/1931/03/24

Funding

  • The Department of Health (Comm): AUD3,509,303.10